Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test.
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...